Advertisement

Use of Lipoprotein(a) in Clinical Practice: A Biomarker Whose Time Has Come.

Last Updated: Monday, 29-Apr-2019 13:00:00 EDT

Use of Lipoprotein(a) in Clinical Practice: A Biomarker Whose Time Has Come. 

A Scientific Statement from the National Lipid Association

Don P. Wilson, MD, Terry A. Jacobson, MD, Peter H. Jones, MD, Marlys L. Koschinsky, PhD, Catherine J. McNeal, MD, PhD, Børge G. Nordestgaard, MD, DMSc, Carl E. Orringer, MD
 

Highlights:

  • Causal association between high lipoprotein(a) [Lp(a)] and atherosclerotic cardiovascular disease–related events and mortality.
  • Laboratory methods and population-based considerations for Lp(a) cut points.
  • When to measure Lp(a) in adults and youth.
  • Treatment implications in primary and secondary prevention.
 
Read Full Statement

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service